Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy (Q39652063)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 2011

Language	Label	Description	Also known as
English	Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy	scientific article published on October 2011

Statements

scholarly article

1 reference

Europe PubMed Central

13 September 2017

Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy (English)

1 reference

Europe PubMed Central

13 September 2017

4

1 reference

Europe PubMed Central

13 September 2017

Leo A van Grunsven

6

1 reference

Europe PubMed Central

13 September 2017

Serge Muyldermans

7

1 reference

Europe PubMed Central

13 September 2017

Marleen Keyaerts

object named as

Marleen Keyaerts

2

0 references

author name string

Lea Olive Tchouate Gainkam

1

1 reference

Europe PubMed Central

13 September 2017

Vicky Caveliers

3

1 reference

Europe PubMed Central

13 September 2017

Christian Vanhove

5

1 reference

Europe PubMed Central

13 September 2017

Tony Lahoutte

8

1 reference

Europe PubMed Central

13 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2011

1 reference

Europe PubMed Central

13 September 2017

Molecular Imaging and Biology

1 reference

Europe PubMed Central

13 September 2017

13

1 reference

Europe PubMed Central

13 September 2017

5

1 reference

Europe PubMed Central

13 September 2017

940-948

1 reference

Europe PubMed Central

13 September 2017

https://scigraph.springernature.com/pub.10.1007/s11307-010-0428-4

0 references

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Clinical implications of the mechanism of epidermal growth factor receptor inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Clinical and economic value of screening for Kras mutations as predictors of response to epidermal growth factor receptor inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Correlating EGFR expression with receptor-binding properties and internalization of 64Cu-DOTA-cetuximab in 5 cervical cancer cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Potent enzyme inhibitors derived from dromedary heavy-chain antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Improved quantification in single-pinhole and multiple-pinhole SPECT using micro-CT information

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Three-pinhole collimator to improve axial spatial resolution and sensitivity in pinhole SPECT.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

AMIDE: a free software tool for multimodality medical image analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D: -luciferin: effect on intensity, time kinetics and repeatability of photon emission.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Whole-body FDG-PET/CT on rheumatoid arthritis of large joints

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Molecular imaging of EGFR kinase activity in tumors with 124I-labeled small molecular tracer and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Nanobodies as tools for in vivo imaging of specific immune cell types

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Structural basis for inhibition of the epidermal growth factor receptor by cetuximab

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Monitoring luciferase-labeled cancer cell growth and metastasis in different in vivo models.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Bioluminescent imaging of melanoma in live mice

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Erlotinib activates mitochondrial death pathways related to the production of reactive oxygen species in the human non-small cell lung cancer cell line A549.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Tumor dependence on the EGFR signaling pathway expressed by the p-EGFR:p-AKT ratio predicts erlotinib sensitivity in human non-small cell lung cancer (NSCLC) cells expressing wild-type EGFR gene

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Using fluorodeoxythymidine to monitor anti-EGFR inhibitor therapy in squamous cell carcinoma xenografts

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0428-4

21 January 2018

Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20865332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR targeting of solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/20865332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20865332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20865332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20865332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo and in vitro uptake of 111In, delivered with the affibody molecule (ZEGFR:955)2, in EGFR expressing tumour cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20865332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20865332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular imaging application of radioiodinated anti-EGFR human Fab to EGFR-overexpressing tumor xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/20865332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11307-010-0428-4

1 reference

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39652063&oldid=1851000501"